OcrelizumabDrug intolerance and lack of efficacy : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2019卷 / 1期

关键词：

D O I：

10.1007/s40278-024-64275-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：362 / 362

相关论文

共 50 条

[1] DoxorubicinDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1980 (1) : 156 - 156
[2] NilotinibDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 326 - 326
[3] CarbamazepineDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2031 (1) : 90 - 90
[4] SodiumDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1969 (1) : 333 - 333
[5] AspirinGastrointestinal intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2037 (1) : 60 - 60
[6] Multiple drugsDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 205 - 205
[7] Multiple drugsGastrointestinal intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 267 - 267
[8] Infliximab/mesalazineDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 232 - 232
[9] Multiple drugsDrug intolerance and lack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 288 - 288
[10] Gemcitabine/TrabectedinDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 234 - 234

← 1 2 3 4 5 →